<DOC>
	<DOCNO>NCT02025309</DOCNO>
	<brief_summary>Sugammadex , modify Î³-cyclodextrin selective relaxant-binding agent reverse effect steroidal neuromuscular block agent , rocuronium vecuronium . It show activity encapsulate . Likewise , steroid hormone drug like flucloxacillin , toremifene , fusidic acid also effect . Thus , assume methylprednisolone would also encapsulate sugammadex decrease efficiency , study aim compare recovery time recuronium-induced muscle relaxation reversal sugammadex patient receive intraoperative methylprednisolone . After institutional review board ( IRB ) approval informed consent , 100 patient enrol prospective , single center , control study . Anaesthesia induce propofol ( 3mg/kg ) rocuronium ( 0.6 mg/kg ) , follow sevoflurane maintenance . Patients divide two group ( Group M , n : 53 group C , n : 47 , methylprednisolone administer group control group respectively ) accord requirement methylprednisolone administration dictate type surgical procedure . Neuromuscular blockade monitor use calibrate train-of-four ( TOF-Carescape B 650 NMT , GE , Connecticut , USA ) . Once rocuronium-induced neuromuscular blockade recovers spontaneously TOF-count-two , patient receive 2.0 mg/kg sugammadex . Neuromuscular monitoring continue recovery TOF ratio 0.9 ulnar nerve . The time recovery TOF 0.7 0.9 compare group . The statistical analysis perform use Student T Test Mann-Whitney U test .</brief_summary>
	<brief_title>Intraoperative Methylprednisolone Sugammadex</brief_title>
	<detailed_description />
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>patient operate general anesthesia endothracheal intubation . 1865 year old ASA II Neuromuscular desease Renal desease Liver failure Hypersensitivity medication use study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>train four</keyword>
	<keyword>neuromuscular recovery</keyword>
	<keyword>sugammadex</keyword>
</DOC>